Sarah Shelton, PsyD, MPH, MSCP—President/Chair of the National Register’s Board of Directors & Registrant since 2007—received the Presidential Leadership Award at the Annual APA Convention in Chicago, Illinois from Division 55 for her contributions in the field of psychopharmacology and prescriptive authority for psychologists.
Dr. Shelton received her PsyD in clinical health psychology from Spalding University in 2005. She was appointed Chief Resident at Northeastern Ohio Universities College of Medicine for her internship year. She then completed two postdoctoral fellowships at the Medical College of Georgia in medical psychology and behavioral medicine and also earned a Master of Public Health degree. She completed graduate training in Forensics at The Chicago School of Professional Psychology and earned a Postdoctoral Masters of Science in Clinical Psychopharmacology at Fairleigh Dickinson University. She is a licensed psychologist in Kentucky, Illinois, Indiana, Tennessee, and Ohio and has been in private practice for over a decade, specializing in medical and forensic psychology assessment and expert witness testimony in her multi-state multi-disciplinary private practice. She is the Clinical Director of the Integrative Behavioral Health Scholars Program for Spalding University’s doctoral program in clinical psychology, where she trains and supervises doctoral psychology students working in primary care settings. Additionally, she is a course developer and professor at The Chicago School of Professional Psychology in their Master of Science in Clinical Psychopharmacology program, equipping psychologists in Illinois with the ability to prescribe psychotropic medications. She is also faculty in a Criminal Justice graduate program and has taught in graduate Public Health programs. Dr. Shelton is past President of the Kentucky Psychological Association, holds an appointment on a committee for the APA Div 41 American Psychology-Law Society, and is the Director of Continuing Education for APA Div 55 American Society for the Advancement of Pharmacotherapy.